Nitin Bhalachandra Dharmadhikari

USPTO Granted Patents = 26 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 147(Granted Patents)

Location History:

State of Maharashtra, IN (2019)
Maharashtra, IN (2003 - 2022)
Mumbai, IN (2010 - 2022)

Company Filing History:

20 out of 64

Sun Pharma Advanced Research Company Limited

patents

5 out of 149

Sun Pharmaceutical Industries Limited

patents

1 out of 1

Sun Pharmaceutical Advanced Research Centre Limited

patent

Years Active: 2003-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12194153 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2025-01-14),

2. 11439600 - Abuse deterrent oral solid dosage form (2022-09-13),

3. 11351123 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2022-06-07),

4. 11273126 - Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N'-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide (2022-03-15),

5. 10226428 - Oral drug delivery system (2019-03-12),

6. 10213387 - Oral drug delivery system (2019-02-26),

7. 10123943 - Portable device for cutting a capsule (2018-11-13),

8. 9980917 - Abuse deterrent immediate release coated reservoir solid dosage form (2018-05-29),

9. 9717800 - Fingolimod containing stable composition (2017-08-01),

10. 9642811 - Abuse deterrent immediate release biphasic matrix solid dosage form (2017-05-09),

11. 9616029 - Abuse deterrent immediate release coated reservoir solid dosage form (2017-04-11),

12. 9610269 - Method of treating a disease condition susceptible to baclofen therapy (2017-04-04),

13. 9173948 - Fingolimod containing stable composition (2015-11-03),

14. 8535717 - Pharmaceutical composition (2013-09-17),

15. 8470367 - Oral drug delivery system (2013-06-25),

Title: Innovator Spotlight: Nitin Bhalachandra Dharmadhikari

Introduction

Nitin Bhalachandra Dharmadhikari is a prominent inventor from the State of Maharashtra, India. With a remarkable achievement of 26 patents to his name, he has significantly contributed to the field of pharmaceutical innovations.

Latest Patents

Nitin's latest inventions include two notable patents. The first is an "Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide," which describes an oral solid dosage form comprising a mixture of a specified compound and a fusible polymeric carrier, along with optionally pharmaceutically acceptable excipients, where the mixture is an amorphous dispersion. The second patent is titled "Abuse deterrent oral solid dosage form," focusing on a formulation designed to deter misuse through its innovative composition.

Career Highlights

Throughout his career, Nitin has worked with esteemed organizations, including Sun Pharma Advanced Research Company Limited and Sun Pharmaceutical Industries Limited. His role in these companies has enabled him to push the boundaries of pharmaceutical research and development, paving the way for innovative solutions to complex health challenges.

Collaborations

Nitin has collaborated with talented professionals such as Yashoraj Rupsinh Zala and Dilip Shanghvi. Their joint efforts on various projects have undoubtedly enriched the pharmaceutical industry, resulting in groundbreaking advancements.

Conclusion

In summary, Nitin Bhalachandra Dharmadhikari's contributions to the field of pharmaceuticals through his inventions and patents demonstrate his commitment to innovation. His work not only enhances drug formulations but also addresses significant concerns related to drug abuse, making him a noteworthy figure in today’s pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.